Toggle light / dark theme

Agenus and Noetik Collaboration Will Predict Cancer Biomarkers Using the Virtual Cell

Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead immuno-oncology combination, BOT/BAL.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.